Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 300-312 , October 2004

2-deoxy-fluorglucose–positron emission tomography imaging of the brain: Current clinical applications with emphasis on the dementias

  • Ronald L. Van Heertum

      Affiliations

    • Department of Radiology, Kreitchman PET Center, College of Physicians & Surgeons, Columbia University, New York, NY, USA.
    • Corresponding Author InformationAddress reprint requests to Ronald L. Van Heertum, MD, Department of Radiology, Harkness Pavilion HP3-319, 180 Fort Washington Avenue, New York, NY 10032, USA.
    • ,
  • Elizabeth A. Greenstein

      Affiliations

    • Department of Radiology, Kreitchman PET Center, College of Physicians & Surgeons, Columbia University, New York, NY, USA.
    • ,
  • Ronald S. Tikofsky

      Affiliations

    • Department of Radiology, Kreitchman PET Center, College of Physicians & Surgeons, Columbia University, New York, NY, USA.

References 

  1. Iacoboni M , Baron JC , Frackowiak RS , et al.   Emission tomography contribution to clinical neurology . Clin Neurophysiol . 1999;110:2–23
  2. Phelps ME , Huang SC , Hoffman EJ , et al.   Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose (Validation of method) . Ann Neurol . 1979;6:371–388
  3. Derdeyn CP , Grubb RL , Powers WJ . Cerebral hemodynamic impairment (Methods of measurement and association with stroke risk) . Neurology . 1999;53:251–259
  4. Yamauchi H , Fukuyama H , Nagahama Y , et al.   Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET . J Neurol Neurosurg Psychiatry . 1996;61:18–25
  5. Ichise M , Ballinger JR . SPECT imaging of dopamine receptors . [editorial] J Nucl Med . 1996;37:1591–1595
  6. Laruelle M , van Dyck C , Abi-Dargham A , et al.   Compartmental modeling of iodine- 123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects . J Nuc Med . 1994;35:743–754
  7. Phelps Me , Cherry SR . The changing design of positron imaging systems . Clinical Positron Imaging . 1998;1:31–45
  8. Beyer T , Townsend DW , Brun T , et al.   A combined PET-CT scanner for clinical oncology . J Nucl Med . 2000;41:1369–1379
  9. Van Heertum RL , Tikofsky RS . Brain tumors, other disease, and activation . In:  Van Heertum RL ,  Tikofsky RS editor. Functional Cerebral SPECT and PET Imaging . 3rd ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 275–312
  10. Biersack HJ , Grunwal F , Kropp J . Single photon emission computed tomography imaging of brain tumors . Semin Nucl Med . 1991;21:2–10
  11. Ebmeiier KP , Booker K , Gregor A , et al.   Single photon emission computed tomography in long term survivors of adult brain tumours . J Neurol Neurosurg Psychiatry . 1994;57:729–733
  12. Rubinstein R , Karger H , Pietrzyk U , et al.   Use of (201)Thallium brain SPECT, image registration, and semi-quantitative analysis in the follow-up of brain tumors . Eur J Radiol . 1996;21:188–195
  13. Kessler LS , Rjuiz A , Donovan MJ , et al.   Thallium-201 brain SPECT of lymphoma in AIDS patients (Pitfalls and technique optimization) . AJNR Am J Neuroradiol . 1998;19:1105–1109
  14. Mountz JM , Deutsche G , Kuzniecky R , et al.   Brain SPECT (1994 update) . In:  Freeman LM editors. Nuclear Medicine Annual 1994 . New York: Raven Press; 1994;p. 1–54
  15. Mountz JM , Stafford-Schuck K , McKeever PE , et al.   Thallium-201 SPECT tumor/cardiac ratio estimation of residual astrocytoma . J Neurosurg . 1988;88:705–709
  16. Kim KT , Black KL , Marciano D , et al.   Thallium-201 SPECT imaging of brain tumors (methods and results) . J Nucl Med . 1990;31:965–969
  17. Soler C , Beauchesne P , Maatougui K , et al.   Technetium-99m-sestamibi brain single-photon-emission tomography for detection of recurrent gliomas after radiation therapy . Eur J Nucl Med . 1998;25:1649–1657
  18. Schwartz RB , Carvalo PA , Alexander E , et al.   Radiation necrosis vs high-grade recurrent glioma (differentiation by using dual-isostope SPECT with 201 Tl and Tc-HMPAO) . AJNR . 1992;12:1187–1192
  19. Papazyan J-P , Delavelle J , Burkhard P , et al.   Discrepancies between HMPAO and ECD SPECT imaging in brain tumors . J Nucl Med . 1997;38:592–596
  20. Soricelli A , Cucolo A , Varrone A , et al.   Technetium-99m-tetrofosmin uptake in brain tumors by SPECT (comparison with thallium-201 imaging) . J Nucl Med . 1998;39:802–806
  21. Barker FG , Chang SM , Valk PE , et al.   (18)Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma . Cancer . 1997;79:115–126
  22. Deshmukh A , Scott JA , Palmer EL , et al.   Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma . Clin Nucl Med . 1996;21:720–725
  23. Ericson K , Kihlstrom I , Mogard J , et al.   Positron emission tomography using (18)F-fluorodeoxyglucose in patients with stereotactally irradiated brain metastases . Stereotact Funct Neurosurg . 1996;66(suppl):214–224
  24. Kole AC , Neweg OF , Pruim J , et al.   Detection of unknown occult primary tumors using positron emission tomography . Cancer . 1998;82:1160–1166
  25. Delbeke D . Oncological applications of FDG PET imaging (Brain tumors, colorectal cancer, lymphoma and melanoma) . J Nucl Med . 1999;40:591–603
  26. Connolly LP , Drubach LA , Treves ST . Applications of nuclear medicine in pediatric oncology . Clin Nucl Med . 2002;27:117–125
  27. Utriainen M , Metsahonkala L , Salmi TT , et al.   Metabolic characterization of childhood brain tumors (comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography) . Cancer . 2002;95:1376–1386
  28. Pirotte B , Goldman S , Salzberg S , et al.   Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children (experience in 9 cases) . Pediatr Neruosurg . 2003;38:146–155
  29. Ribom D , Eriksson A , Hartman M , et al.   Positron emission tomography (11)C- methionine and survival in patients with low-grade gliomas . Cancer . 2001;92:1541–1549
  30. De Witte O , Goldberg I , Wikler D , et al.   Positron emission tomography with injection of methionine as a prognostic factor in glioma . J Neurosurg . 2001;95:746–750
  31. Sorensen J , Savitcheva I I , Engler H , et al.   Utility of PET and 11C-Methionine in the paediatric brain tumors . Clin Positron Imaging . 2000;3:157
  32. Kurtze JF . Epidemiology of cerebrovascular disease . In:  Mc Dowell FH ,  Caplan LR editor. Cerebrovascular Survey Report 1985 . Bethesda, MD: National Institutes of Health; 1985;p. 1–34
  33. Sacco RL , Elkind M , Boden-Albala B , et al.   The protective effect of moderate alcohol consumption on ischemic stroke . JAMA . 1999;281:53–60
  34. Van Heertum RL , Rubens AB , Coslett HH . Cerebrovascular disease . In:  Van Heertum RL ,  Tikofsky RS editor. Functional Cerebral SPECT and PET Imaging . 3rd ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 67–126
  35. Van Heertum RL , Miller SH , Mosesson RE . SPECT brain imaging in neurologic disease . Radiol Clin North Am . 1993;31:881–907
  36. Alzheimer A . Uber eine eigenartige Erkankung der Hirnirinde . Allegmeine Zeitschrift fur Psychiatric . 1907;64:146–148
  37. Albert MS , Drachman DA . Alzheimer’s disease (What is it, how many people have it, and why do we need to know?) . Neurology . 2000;56:166–168
  38. Hy LX , Keller DM . Prevalence of AD among whites (A summary by levels of severity) . Neurology . 2000;55:198–204
  39. Van Heertum RL , Tikofsky RS , Rubens AB . Dementia . In:  Van Heertum RL ,  Tikofsky RS editor. Functional Cerebral SPECT and PET Imaging . 3rd ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 127–188
  40. Witthaus E , Ott A , Barendregt JJ , et al.   Burden of mortality and morbidity from dementia . Alzheimer Dis Assoc Disord . 1999;13:176–181
  41. McKhann G , Drachman D , Folstein M , et al.   Clinical diagnosis of Alzheimer’s disease (Report on NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease) . Neurology . 1989;34:939–942
  42. Wetterling T , Kanitz RD , Borgis KJ . Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN) . Stroke . 1996;27:30–36
  43. Small GW , Mazziotta JC , Collins MT , et al.   Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease . JAMA . 1995;273:942–947
  44. Cardebat D , D’Emonet JF , Puel M , et al.   Brain correlates of memory processes in patients with dementia of Alzheimer’s type (A SPECT activation study) . J Cereb Blood Flow Metab . 1998;18:457–462
  45. Elfgren CI , Ryding E , Passant U . Performance on neuropsychological tests related to single photon emission computerised tomography findings in frontotemporal dementia . Br J Psychiatry . 1996;169:416–422
  46. Golan H , Kremer J , Freedman M , et al.   Usefulness of follow-up regional cerebral blood flow measurements by single-photon emission computed tomography in the differential diagnosis of dementia . J Neuroimaging . 1996;16:23–28
  47. Greene JD , Miles K , Hodges JR . Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type . J Neurol . 1996;243:175–190
  48. Kemppainen N , Ruottinen H , Nagron K , et al.   PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD . Neurology . 2000;55:205–209
  49. Stoof JC , Drukarch B , de Boer P , et al.   Regulation of the activity of striatal cholinergic neurons by dopamine . Neuroscience . 1992;47:755–770
  50. Hoffman JM , Hanson MW , Welsh KA , et al.   Interpretation variability of 18FDG-positron emission tomography studies in dementia . Invest Radiol . 1996;31:316–322
  51. Mielke R , Heiss WD . Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia . J Neurol Transm Suppl . 1998;53:237–250
  52. Talbot PR , Lloyd JJ , Snowden JS , et al.   A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? . J Neurol Neurosurg Psychiatry . 1998;64:306–313
  53. Brooks DJ . Functional imaging techniques in the diagnosis of non-Alzheimer dementias . J Neurol Transm Suppl . 1996;47:155–167
  54. Ceballos-Baumann AO , Boecker H , Bartenstein P , et al.   A positron emission tomographic study of subthalamic nucleus stimulation in parkinson disease (enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity) . Arch Neurol . 1999;156:997–1003
  55. Ott BR , Faberman RS , Noto RB , et al.   A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia . Dement Geriatr Cogn Disord . 1997;8:348–354
  56. Corder EH , Saunders AM , Strittmatter WJ , et al.   Gene dose of apolipoprotein E type 4 and the risk of Alzheimer’s disease in late onset families . Science . 1993;261:921–923
  57. Corder EH , Saunders AM , Risch NJ , et al.   Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease . Nat Genet . 1994;7:180–184
  58. Corder EH , Jelic V , Basun H , et al.   No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes . Arch Neurol . 1997;54:273–277
  59. Small GW , Mazziotta JC , Collins MT , et al.   Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease . JAMA . 1995;273:942–947
  60. Reiman EM , Caselli RJ , Yun LS , et al.   Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E . N Engl J Med . 1996;334:752–758
  61. Devous MD , Leroy RF , Homan RW . Single Photon emission computed tomography in epilepsy . Semin Nucl Med . 1990;20: 325-241
  62. Henry TR , Van Heertum RL . PET imaging in the evaluation of epilepsy care . Semin Nucl Med . 2003;32:188–205
  63. Tikofsky RS , Van Heertum RL . Seizure disorders . In:  Van Heertum RL ,  Tikofsky RS editor. Functional Cerebral SPECT and PET Imaging . 3rd ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 189–228
  64. Devous MD , Thisted RA , Morgan GF , et al.   SPECT brain imaging in epilepsy (a meta-analysis) . J Nucl Med . 1998;39:285–293
  65. Devous MD . Comparison of SPECT applications in neurology and psychiatry . J Clin Psychiatry . 1992;53(suppl):13–19
  66. Bavetta S , Nimmon CC , McCabe J , et al.   A prospective study comparing SPET with MRI and CT as prognostic indicators following severe closed head injury . Nucl Med Commun . 1999;15:961–968
  67. Jacobs A , Put E , Ingels M , et al.   Prospective evaluation of technitium-99m- HMPAO SPECT in mild and moderate traumatic brain injury . J Nucl Med . 1994;35:942–947
  68. Newberg AB , Alavi A . Neuroimaging in patients with head trauma . In:  Freeman LM editors. Nuclear Medicine Annua . Philadelphia: Lippincott-Raven Publishers; 1996;p. 195–212
  69. Reid RH , Gulenchyn KY , Ballinger JR , et al.   Cerebral perfusion imaging with technitium-99m HMPAO following cerebral trauma. Initial experience . Clin Nucl Med . 1990;15:383–388
  70. Kant R , Smith-Seemiller L , Isaac G , et al.   Tc-HMPAO SPECT in persistent post-concussion syndrome after mild head injury (Comparison with MRI/CT) . Brain Inj . 1997;11:115–124

PII: S0001-2998(04)00021-2

doi: 10.1053/j.semnuclmed.2004.03.003

Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 300-312 , October 2004

Article Tools

* Image Usage & Resolution